Hernán A. Navarro
Vice President, Discovery Sciences
- NRSA Fellow, Duke-VA Center for Cerebrovascular Research (Duke Stroke Center)
- Research Associate, Dept. of Pharmacology, Duke University Medical Center
- PhD, University of Kentucky
- BS, Duke University
Hernán Navarro, PhD, has more than 20 years of experience in central nervous system pharmacology, with research ranging from the effects of in utero exposure to cholinomimetics on offspring brain and immune function development to the in vitro and in vivo characterization of radioligands and the pharmacological characterization of novel orthosteric or allosteric central nervous system-active compounds.
Dr. Navarro has extensive experience with cell culture and in vitro assay techniques such as FLIPR, 96-well-based phenotypic assays, radioligand binding, and synaptosomal uptake or release of radiolabeled compounds. He also has experience with neurobehavioral techniques such as Morris water maze, locomotor activity, and auditory startle. He is currently interested in establishing non-mammalian behavioral assays for use in drug discovery and toxicology.